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ABSTRACT : The active fraction (AF) from lxora coccinea flowers prevented the decrease in 
haemoglobin levels and leucocyte counts of Dalton’s lymphoma tumour bearing mice, treated 
with cyclophosphamide (CYP). It also significantly increased the life span of tumour bearing 
mice, treated with cyclophosphamide. Serum glutamate pyruvate transaminase (SGPT) and 
serum alkaline phosphatase (SAKP) levels of tumour bearing mice treated with CYP were 
decreased significantly by combination therapy with I.coccinea AF. indicating protection against 




Cyclophosphamide (CYP), an alkylating 
agent is a broad spectrum anti - cancer drug, 
which has been shown to be inactive in 
vitro, but was found to be activated in the 
liver by the microsomal       enzyme system 
in the presence of oxygen and reduced 
NADPH to cytotoxic metabolites 1,2.  The 
high therapeutic ndex of CYP was shown to 
be due to the metabolite, 4-
hydroxycyclophosphamide and a 
phosphoramide derivative 3. It was shown 
that free radicals are formed due to the 
activation of CYP and produce tissue 
injury4. Toxic syndromes of CYP include 
the suppression of white blood cells, nausea, 
vomiting, gonadal atrophy and renal and 
bladder injury. It has been reported that 
sulphhydryl agents such as MPG (2-
mercaptopropionylglycine) and WR 2721 
(aminoethylphosphorthioc acid) reduce the 
toxicity of CYP by preventing free radical 
accumulation and promoting repair 5. 
Considerable interest has been focused on 
the isolation of phytochemicals that might 
be administered along with CYP to reduce 
its toxicity. The flowers of lxora coccinea L. 
(Rubiaceae) are extensively used in 
Ayurvedic medicine6. The cytotoxic and 
antitumour properties of the flowers have 
been              studied 7.  We have already 
reported the chemoprotective effect of I. 
Coccinea flowers on CYP - induced toxicity 
in normal mice 8. In this paper, the protective 
effects of the active fraction of I.coccinea 
flowers against CYP induced toxicity in 
Dalton’s Lymphoma Ascites (DLA) turnour 
bearing mice is reported. 
 




CYP (Endoxan Asta) was purchased from 
German Remedies Limited, Thane, Mumbai.  
It  was diluted to the required concentrations 
with distilled water. All other chemicals and 
reagents were of   analytical grade, from 
Sisco Research Laboratories, Mumbai. 
 
Plant material and extraction  procedure 
 
I. coccinea flowers were obtained from the 
herbal garden of the Institute, and 
authenticated by Dr.N.Mohanan, plant 
Pages 23 - 29taxonomist.  A voucher specimen had been 
deposited at the herbarium of the Institute 
(Accession No.8735 of 21/1/1992) 
 
The preparation of the active fraction (AF) 
 
The AF of I. coccinea flowers was prepared 
as described elsewhere7.  Briefly, the shade - 
dried flowers were powdered and 100g of 
the powder was extracted with 500ml n-
hexane in a Soxhlet for 48h.  This was 
evaporated under reduced pressure to obtain 
a yellow residue.(4.5 g). The residue was 
loaded on a Silica gel column and eluted 
with hexane - 5% ethyl acetate mixture.   
This fraction was concentrated in vacuo to 
obtain a white powder  (450 mg).This is the 
AF.  It was reconstituted in 6 mM phosphate 
buffer saline (PBS, pH 7.4), containing 





Swiss albino mice, males, 8-10 weeks old, 
weighing 25-30g were obtained from the 
animal house of the Institute.  They were 





DLA tumour cells propagated i.p., in mice 
were obtained from Amala Cancer Research 
Centre, Thrissur, Kerala.  
 
CYP treatment of tumour - bearing mice 
 
Four groups of mice (7/group) were used for 
the study.  One million tumour cells were 
transplanted i.p., into all the 4 groups. 
 
24h after tumour transplantation, CYP (50 
mg/kg) was injected i.p., for 5 alternate days 
to the animals of the first group.  The second 
group was given i.p., 100 mg/kg of 
I.coccinea AF, and 30 min before CYP 
treatment.  The third group was given 
I.coccinea  AF (100mg/kg) only and the 
fourth group was the control, which received 
PBS containing 0.04% Tween-80. The 
treatment was continued for 4 alternate days.  
The mortality due to turnour burden and 
CYP toxicity was recorded daily.  The 
percentage increase in life span (ILS %) of 
the animals was calculated. The experiment 
was repeated twice. 
 
Haematological and biochemical  studies 
 
Peripheral blood for the various assays was 
collected from the caudal vein at different 
levels.  Total leucocyte counts were made 
using a haemocytometer.  Haemoglobin 
content was measured             using Sahli’s 
haemoglobinometer. The serum glutamate 
pyruvate transaminase (SGPT) and serum 
alkaline phosphatase (SAKP) levels were 
determined by standard methods 9-10.  
 
Acute toxicity study 
 
Mice were fasted overnight but was given 
boiled water ad libitum. Doses of 100, 200 
and 400mg /kg of the AF were administered 
i.p., to the animals.  They were observed for 





Differences between control and treated 
animals were evaluated for significance by 
Student’s ‘t’ test.11 
 
RESULTS AND DISCUSSION 
 
Table 1 shows the increase in life span of 
DLA turnour bearing animals treated with 
CYP and I.coccinea AF. There was a 48% 
increase in life span of the combination 
treated groups, compared to the CYP treated 
tumour group  (Table 1). 
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CYP treatment gradually lowered the total 
leucocyte count and  haemoglobin levels in 
turnour bearing mice.  But these levels were 
improved significantly in tumour bearing 
animals given I.coccinea along with CYP 
(Figs 1,2) 
 
The SGPT and SAKP levels were 
significantly increased in the CYP treated 
tumour group.  The combination therapy 
with CYP and I.coccinea AF reduced SGPT 
and SAKP levels, compared to CYP treated 
turnour controls (Table 2) 
 
In the acute toxicity study, no mortality 
occurred within 24h with any of the doses of 
AF tested.  The treated animals did not show 
any changes in general behaviour during the 
study. 
 
In the present study, I.coccinea AF was 
found to reduce CYP induced toxicity in 
turnour bearing mice.  The combination 
treatment of CYP and I.coccinea AF on 
turnour bearing mice resulted in an increase 
in life span, which indicated the 
chemoprotective effect of the AF. Lowered 
levels of SGPT and SAKP in the 
combination treated group revealed 
protection by AF against liver necrosis. 
SGPT and SAKP are sensitive tests to detect 
hepatic disease. Elevated levels of serum 
enzymes are indicator of cellular leakage 
and loss of functional integrity of cell 
membranes of the liver 12. CYP is activated 
in the liver to cytotoxic metabolites 2.   Free 
radicals are formed during the activation of 
CYP and cause liver tissue injury4, leading 
to increased SAKP and SGPT levels as 
observed in the present study.  Therefore the 
present study suggests that I.coccinea  AF 
reduces the toxicity of CYP by preventing 
free radical accumulation and promoting 
repair. Previous studies 13,14  had shown that 
I.coccinea  AF contained the triterpenoid 
ursolic acid, which has very potent 
hepatoprotective effects, comparable to that 
of silymarin.  This is due to its membrane 
stabilising and anti - oxidant effects 15. 
Ursolic acid is known to protect from liver 
injury in mice 16.  
 
I.coccinea AF is non - toxic, from the results 
of our study.  This is not surprising as it is 
an ingredient of several Ayurvedic 
formulations. 
 
Our results also showed that I.coccinea 
protected the haemopoetic system like the 
blood cells (RBC, WBC) and the bone 
marrow, which is the  primary site of  blood 
cell formation 17. 
I.coccinea  AF is reported to possess anti 
tumour properties7. Therefore it helped to 
reduce the turnour burden by itself and also 
helped to reduce the toxicity of the anti - 
cancer drug, CYP, when used in 
combination with it. 
 
The present study thus warrants use of 
I.coccinea AF in combination chemotherapy 
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TABLE - 1 
 




            Treatment                                  Mean survival time                         % increase in life span 
                                        (Days)                                               (% ILS)  
______________________________________________________________________________ 
 
  DLA (Control)                                    25.57 + 3.18                                              -  
 
  DLA +                                          40.42 + 2.54                                              -  
  CYP ( 50 mg/kg) 
 
  DLA +                                         59.00 + 3.16                                           47.85 * 
 CYP  (50mg/kg)+ 
  I. coccinea (100 mg / kg) 
 
 
* P < 0.05 vs CYP control, n = 21 
 
TABLE - 2 
Effect of I.coccinea AF on the serum enzymes of CYP treated DLA tumour bearing mice. 
 
 
Treatment                                      SGPT (IU/L)                                      SAKP (KA units) 
 
            Day 3                Day 7                          Day 3                 Day 7 
 
DLA (control)                             6.8 ± 0.02      5.9 ± 0.62      4.1 ± 0.63       4.8 ± 0.73 
 
DLA +  
CYP (50 mg / kg)             128.8 ± 1.23      16.9 ± 2.09    7.3 ± 0.97      8.3 ± 1.11 
 
DLA + CYP (50mg / kg) +  
I.coccinea (100mg / kg)   8.9 ± 1.23*     12.8 ± 2.09*    5.2 ± 0.73*       6.1 ± 1.24* 
  
DLA +  
I.coccinea (100 mg/kg)    6.6 ± 0.61      6.9 ± 0.64    4.9 ± 0.75       5.9 ± 0.57 
 
* P < 0.05 vs CYP control, n = 21 
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Fig. 1 - Total leucocyte count of DLA turnour bearing mice, treated with CYP (50 mg / kg), with 
or without I.coccinea. Values are mean + SD, n=21 **P<0.01,vs.DLA + CYP 
 
Fig. 2 - Haemoglobin level of DLA turnour bearing mice, treated with CYP (50mg/kg), with or 
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